iShares Genomics Immunology and Healthcare ETF
IDNA
48 hedge funds and large institutions have $44.4M invested in iShares Genomics Immunology and Healthcare ETF in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 15 closing their positions.
55% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 11
1.63% more ownership
Funds ownership: 39.23% → 40.86% (+1.6%)
9% less capital invested
Capital invested by funds: $48.8M → $44.4M (-$4.46M)
17% less funds holding
Funds holding: 58 → 48 (-10)
67% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Raymond James Financial
St Petersburg,
Florida
|
+$2.16M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.68M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$1.43M |
| 4 |
Morgan Stanley
New York
|
+$363K |
| 5 |
WBG
Wharton Business Group
Malvern,
Pennsylvania
|
+$332K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
-$2.13M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.26M |
| 3 |
TW
Transform Wealth
Greenwood Village,
Colorado
|
-$721K |
| 4 |
Jane Street
New York
|
-$662K |
| 5 |
LWM
Laidlaw Wealth Management
New York City,
New York
|
-$477K |
IDNA Hedge Fund Activity: Q1 2025 in Review
48 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in iShares Genomics Immunology and Healthcare ETF (IDNA) for Q1 2025, worth a combined $44.4M — down 9.1% from $48.8M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of IDNA and 5 opened new positions — a net loss of 10 holders — while 11 trimmed existing stakes and 17 added.
The largest buyer was Raymond James Financial, adding an estimated $2.16M. The largest seller was Flow Traders U.S., exiting entirely with an estimated $2.13M sold.
- 48 institutional investors held iShares Genomics Immunology and Healthcare ETF (IDNA) as of Q1 2025, down from 58 in Q4 2024.
- Funds reported $44.4M of iShares Genomics Immunology and Healthcare ETF stock for Q1 2025, down 9.1% quarter-over-quarter.
- 5 funds opened new iShares Genomics Immunology and Healthcare ETF positions in Q1 2025 and 15 closed out, a net change of -10 holders.
- The largest iShares Genomics Immunology and Healthcare ETF buyer in Q1 2025 was Raymond James Financial, an estimated $2.16M added.
- The largest iShares Genomics Immunology and Healthcare ETF seller in Q1 2025 was Flow Traders U.S., an estimated $2.13M sold.
Based on aggregated 13F filings for Q1 2025.